Publications by Dr Kelly Coffey - ePrints

Browsing publications by Dr Kelly Coffey.

Newcastle Authors	Title	Year
Dr Emma Lishman-Walker Dr Kelly Coffey	Casein Kinase 1α—A Target for Prostate Cancer Therapy?	2024
Rebecca Garnham Dr Daniel Geh Ryan Nelson Erik Ramon Gil Laura Wilson et al.	ST3 beta-galactoside alpha-2,3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer	2024
Zainab Alebady Dr Mahsa Azizyan Dr Sirintra Nakjang Dr Emma Lishman-Walker Jesslyn Choo et al.	CDC20 is regulated by the histone methyltransferase, KMT5A, in castration resistant prostate cancer	2023
Rebecca Garnham Dr Daniel Geh Ryan Nelson Erik Ramon Gil Laura Wilson et al.	ST3Gal1 synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer	2023
Dr Kelly Coffey	Targeting the Hippo pathway in prostate cancer: What’s new?	2021
Alex Bainbridge Dr Scott Walker Joseph Smith Yi Min Ng Ng Huw Thomas et al.	IKBKE activity enhances AR levels in advanced prostate cancer via modulation of the Hippo pathway	2020
Dr Frida Ponthan Professor Olaf Heidenreich Dr Kelly Coffey	Gene Silencing by RNAi in Mammalian Cells	2015
Dr Mark Wade Dominic Jones Laura Wilson Dr Jacqueline Stockley Dr Kelly Coffey et al.	The histone demethylase enzyme KDM3A is a key estrogen receptor regulator in breast cancer	2015
Dr Urszula McClurg Victoria Harle Dr Scott Walker Dr Kelly Coffey Dr Luke Gaughan et al.	Ubiquitin-specific protease 12 interacting partners Uaf-1 and WDR20 are potential therapeutic targets in prostate cancer	2015
Dr Urszula McClurg Victoria Harle Dr Kelly Coffey Dr Steven Darby Hollie Ramsey et al.	Usp12 a novel AR co-regulator and PCa biomarker?	2014
Dr Urszula McClurg Victoria Harle Dr Kelly Coffey Dr Steven Darby Hollie Ramsey et al.	Deubiquitinating Enzyme Usp12 Is a Novel Co-activator of the Androgen Receptor	2013
Dr Luke Gaughan Dr Kelly Coffey Dr Mark Wade Sandy Tse	KDM4B is a Master Regulator of the Estrogen Receptor Signalling Cascade	2013
Dr Kelly Coffey Lynsey Rogerson Claudia Ryan-Munden Dhuha Alkharaif Dr Jacqueline Stockley et al.	The lysine demethylase, KDM4B, is a key molecule in androgen receptor signalling and turnover	2013
Dr Kelly Coffey Dr Tim Blackburn Susan Cook Emeritus Professor Bernard Golding Professor Roger Griffin et al.	Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer	2012
Dr Stuart Williamson Dr Anastasia Hepburn Laura Wilson Dr Kelly Coffey Claudia Ryan-Munden et al.	Human α₂β₁^HI CD133^+VE Epithelial Prostate Stem Cells Express Low Levels of Active Androgen Receptor	2012
Dr Kelly Coffey Professor Craig Robson	Regulation of the androgen receptor by post-translational modifications	2012
Dr Prabhakar Rajan Caroline Dalgliesh Pip Carling Dr Sushma Grellscheid Dr Kelly Coffey et al.	Identification of Novel Androgen-Regulated Pathways and mRNA Isoforms through Genome-Wide Exon-Specific Profiling of the LNCaP Transcriptome	2011
Dr Luke Gaughan Dr Jacqueline Stockley Nan Wang Dr Stuart McCracken Dr Kelly Coffey et al.	Regulation of the androgen receptor by SET9-mediated methylation	2011
Dr Kelly Coffey Professor Craig Robson Professor Hing Leung	Upregulated FGFR1 expression is associated with the transition of hormone-naive to castrate-resistant prostate cancer	2011
Dr Kelly Coffey Professor Craig Robson Professor Hing Leung	NF-κB activation upregulates fibroblast growth factor 8 expression in prostate cancer cells	2006
Dr Kelly Coffey	[PhD Thesis] Gene expression analysis in prostate cancer: Effects of Trichostatin A	2005
Dr Kelly Coffey Vincent Gnanapragasam Professor Craig Robson Professor Hing Leung	Activation of fibroblast growth factor 8 (FGF8) expression by trichostatin a: A potential role for PI3 kinase	2004
Professor Hing Leung Dr Kelly Coffey	Analysis of Wnt gene expression in prostate cancer: Mutual enhibition by WNT11 and the androgen receptor	2004